Spectra Intelligence was founded in 2005 to provide syndicated market research information to the global life sciences industry and capital investment sector. The company derives its name from the Latin 'Spectare' and 'Specere' which means to observe or look at, but also means extensive range or series. The name reflects our hopes and commitments to provide companies and institutions with a repertoire of focused, cutting-edge, authoritative, and forward-thinking market research studies and conferences to stimulate commercial enterprise, innovation, and industrial growth.

Spectra's management and advisory team comprises leading industry analysts, academics, and established senior-level executives who together work to produce outstanding and highly regarded competitive intelligence publications that are essential for companies to advance corporate strategy and facilitate decision-making at the senior executive level.

Global Services

Spectra Intelligence aims to be a leading knowledge provider for the global pharmaceutical and biotechnology industry. Our services range from the publication of a series of syndicated high calibre market research reports to consultancy services and conference production to help identify product market and equity investment opportunities as well as keeping industry up-to-date with trends and developments.

Companies and institutions are encouraged to contact us in confidence for specific data needs or research requests regarding therapeutic areas, products, technologies, and market research and analysis. Spectra's experienced industry analysts also offer competence in undertaking third-party assessments for licensing and acquisition activities within the industry to match core activities and portfolios with suitable partners based on our extensive coverage of all therapeutic drug markets, devices, and biotechnology products.

Privacy Policy